Nanovalent Pharmaceuticals Inc.

Bozeman, MT

UEI
NFPTYA1R6KY1
CAGE
4LGY2
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
351 Evergreen Dr Ste B, Bozeman, MT 59715, USA
Website
nanovalentpharma.com
Founded
2006
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Nanovalent Pharmaceuticals Inc. registered in SAM.gov?

Yes. Nanovalent Pharmaceuticals Inc.'s SAM.gov registration is active through January 6, 2027.

What is Nanovalent Pharmaceuticals Inc.'s most recent federal award?

Nanovalent Pharmaceuticals Inc.'s most recent federal grant award is Tumor antigen targeted nanoparticle therapy for glioblastoma (GBM) (R42CA281707), from National Cancer Institute (NIH), on August 8, 2023.

On GovTribe

See Nanovalent Pharmaceuticals Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors